+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global mHealth Apps Market (2022-2027) by Product & Service Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 173 Pages
  • June 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5635863

Big-data in mHealth apps is the future of Healthcare

The Global mHealth Apps Market is estimated to be USD 45.94 Bn in 2022 and is expected to reach USD 118.86 Bn by 2027, growing at a CAGR of 20.94%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global mHealth Apps Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global mHealth Apps Market is segmented based on Product & Service, and Geography.
  • By Product & Service, the market is classified into mHealth Apps, mHealth Services, and Services.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories Ltd., AstraZeneca PLC, AT&T Inc., Johnson And Johnson Services, Inc., Novartis Ag, Pfizer, Inc., Qualcomm Technologies Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global mHealth Apps Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global mHealth Apps Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global mHealth Apps Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global mHealth Apps Market

What is the estimated value of the Global mHealth Apps Market?

The Global mHealth Apps Market was estimated to be valued at $45.94 Billion in 2022.

What is the growth rate of the Global mHealth Apps Market?

The growth rate of the Global mHealth Apps Market is 20.9%, with an estimated value of $118.86 Billion by 2027.

What is the forecasted size of the Global mHealth Apps Market?

The Global mHealth Apps Market is estimated to be worth $118.86 Billion by 2027.

Who are the key companies in the Global mHealth Apps Market?

Key companies in the Global mHealth Apps Market include Abbott Laboratories Ltd., AgaMatrix Inc., AirStrip Technologies, Inc., Alivecor, Inc., Allscripts Healthcare Solutions, Inc., AstraZeneca PLC, AT&T Inc., Athenahealth, Inc., Biotelemetry, Inc. and Bristol.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Penetration of Smartphones, Tablets, and Other Mobile Platforms
4.1.2 Increasing Utilization of Connected Devices and mHealth Apps for the Management of Chronic Diseases
4.1.3 Cost Containment in Healthcare Delivery
4.1.4 Increasing Demand for Home Healthcare Se
4.2 Restraints
4.2.1 Lack of Standards and Regulations as Well as Paucity of Reimbursements
4.2.2 Limited Guidance from Physicians in Selecting Apps
4.2.3 Resistance from Traditional Healthcare Providers
4.3 Opportunities
4.3.1 Increasing Incidence of Lifestyle Disorders
4.3.2 Growing Adoption of mHealth Solutions in Other Mobile Platforms
4.3.3 Increasing Adoption of AI and 5G
4.4 Challenges
4.4.1 Authenticity and Reliability
4.4.2 Patent Protection for mHealth Devices and Applications
4.4.3 Lack of Data Security Giving Rise to Concerns Regarding Data Theft and Healthcare Fraud
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global mHealth Apps Market, By Product & Service
6.1 Introduction
6.2 mHealth Apps
6.2.1 Healthcare Apps
6.2.2 Medical Apps
6.2.3 Connected Medical Devices
6.3 mHealth Services
6.3.1 Remote Monitoring Service
6.3.2 Diagnosis & Consultation Services
6.3.3 Treatment Services
6.3.4 Healthcare System Strengthening Services
6.3.5 Fitness & Wellness Services
6.3.6 Prevention Services
7 Americas’ mHealth Apps Market
7.1 Introduction
7.2 Argentina
7.3 Brazil
7.4 Canada
7.5 Chile
7.6 Colombia
7.7 Mexico
7.8 Peru
7.9 United States
7.10 Rest of Americas
8 Europe’s mHealth Apps Market
8.1 Introduction
8.2 Austria
8.3 Belgium
8.4 Denmark
8.5 Finland
8.6 France
8.7 Germany
8.8 Italy
8.9 Netherlands
8.10 Norway
8.11 Poland
8.12 Russia
8.13 Spain
8.14 Sweden
8.15 Switzerland
8.16 United Kingdom
8.17 Rest of Europe
9 Middle East and Africa’s mHealth Apps Market
9.1 Introduction
9.2 Egypt
9.3 Israel
9.4 Qatar
9.5 Saudi Arabia
9.6 South Africa
9.7 United Arab Emirates
9.8 Rest of MEA
10 APAC’s mHealth Apps Market
10.1 Introduction
10.2 Australia
10.3 Bangladesh
10.4 China
10.5 India
10.6 Indonesia
10.7 Japan
10.8 Malaysia
10.9 Philippines
10.10 Singapore
10.11 South Korea
10.12 Sri Lanka
10.13 Thailand
10.14 Taiwan
10.15 Rest of Asia-Pacific
11 Competitive Landscape
11.1 Competitive Quadrant
11.2 Market Share Analysis
11.3 Strategic Initiatives
11.3.1 M&A and Investments
11.3.2 Partnerships and Collaborations
11.3.3 Product Developments and Improvements
12 Company Profiles
12.1 Abbott Laboratories Ltd.
12.2 AgaMatrix Inc.
12.3 AirStrip Technologies, Inc.
12.4 Alivecor, Inc.
12.5 Allscripts Healthcare Solutions, Inc.
12.6 AstraZeneca PLC
12.7 AT&T Inc.
12.8 Athenahealth, Inc.
12.9 Biotelemetry, Inc.
12.10 Bristol-Myers Squibb
12.11 F. Hoffmann-la Roche Ltd.
12.12 GlaxoSmithKline PLC
12.13 iHealth Labs Inc.
12.14 Johnson And Johnson Services, Inc.
12.15 Livongo Health, Inc.
12.16 Masimo Corp.
12.17 Medtronic Minimed, Inc.
12.18 Merck & Co., Inc.
12.19 Nokia Corp.
12.20 Novartis Ag
12.21 OMRON Healthcare, Inc.
12.22 Pfizer, Inc.
12.23 Qualcomm Technologies Inc.
12.24 Samsung Electronics Co. Ltd.
12.25 Telefonica SA
12.26 Vivify Health, Inc.
12.27 Withings SA
13 Appendix
13.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories Ltd.
  • AgaMatrix Inc.
  • AirStrip Technologies, Inc.
  • Alivecor, Inc.
  • Allscripts Healthcare Solutions, Inc.
  • AstraZeneca PLC
  • AT&T Inc.
  • Athenahealth, Inc.
  • Biotelemetry, Inc.
  • Bristol-Myers Squibb
  • F. Hoffmann-la Roche Ltd.
  • GlaxoSmithKline PLC
  • iHealth Labs Inc.
  • Johnson And Johnson Services, Inc.
  • Livongo Health, Inc.
  • Masimo Corp.
  • Medtronic Minimed, Inc.
  • Merck & Co., Inc.
  • Nokia Corp.
  • Novartis Ag
  • OMRON Healthcare, Inc.
  • Pfizer, Inc.
  • Qualcomm Technologies Inc.
  • Samsung Electronics Co. Ltd.
  • Telefonica SA
  • Vivify Health, Inc.
  • Withings SA